Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells
Renata de Freitas Saito, Luciana Nogueira de Sousa Andrade, Silvina Odete Bustos et al. · Frontiers in Immunology · 2022 · Review
Full textCC BY
12 papersQuestions on this topic
Renata de Freitas Saito, Luciana Nogueira de Sousa Andrade, Silvina Odete Bustos et al. · Frontiers in Immunology · 2022 · Review
Full textCC BY
Yoomi Chun, Joungmok Kim · International Journal of Molecular Sciences · 2021 · Review
Full textCC BY
Yu'e Liu, Yihong Sun, Yadong Guo et al. · International Journal of Biological Sciences · 2023 · Review
Full textCC BY
Xingting Bao, Jinhua Zhang, Guomin Huang et al. · Cell Death & Disease · 2021 · Review
Full textCC BY
Yuying Tan, Junjie Li, Guangyuan Zhao et al. · Nature Communications · 2022
Full textCC BY
Zhenzhen Li, Chanjun Sun, Zhihai Qin · Theranostics · 2021 · Review
Full textCC BY
Jianqiang Yang, Chloe Shay, Nabil F. Saba et al. · Experimental Hematology & Oncology · 2024 · Review
Full textCC BY
Shamir Cassim, Milica Vučetić, Maša Ždralević et al. · Cancers · 2020 · Review
Full textCC BY
Huangcan Li, Zhuoying Feng, Ming-Liang He · Theranostics · 2020 · Review
Full textCC BY
Moris Sangineto, Rosanna Villani, Francesco Cavallone et al. · Cancers · 2020 · Review
Full textCC BY
Tulasi Yadati, Tom Houben, Albert Bitorina et al. · Cells · 2020 · Review
Full textCC BY
Diandra Zipinotti dos Santos, Josiany Carlos de Souza, Tatiana Massariol Pimenta et al. · Cell Communication and Signaling · 2023 · Review
Full textCC BY